TransCan Genomics Inc.

What TransCan Genomics Inc. does

TransCan Genomics Inc. is a privately held Canadian company headquartered in Vancouver that provides clinical hereditary cancer testing, genomic data management, and reporting services to healthcare providers. Its functional focus is on the hereditary cancer segment of clinical genomics, supplying diagnostic assays and the data infrastructure required to interpret, store, and report results back to clinicians. The company operates in a regulated clinical laboratory context, where hereditary cancer testing requires appropriate accreditation and clinical reporting standards, and where genomic data management is an essential part of delivering actionable results to ordering physicians. The company is described as serving healthcare providers specifically, indicating a B2B go-to-market model rather than direct-to-consumer testing.

Beyond this short functional description, the publicly accessible evidence base is thin. The company website (transcangenomics.ca) returned only a loading/verification page at the time of data collection, and no third-party disclosures of headcount, funding, revenue, partnerships, customer logos, management team, regulatory certifications, patents, product SKUs, or pricing were available in the supplied source material. As a result, the business model mechanics (e.g., per-test pricing, reimbursement strategy, payor mix, test menu breadth, contract structure with provincial health systems or private clinics) cannot be characterized from the input. The company is confirmed to be private, domiciled in Canada, and operating in the clinical genomics sub-sector, but the depth of its commercial activity, capital base, and operational scale is not ascertainable from the available data.

Name

TransCan Genomics Inc.

Website

https://transcangenomics.ca

Company type

Private

Operating status

Operating

Short description

TransCan Genomics Inc. is a Vancouver-based private Canadian company that provides clinical hereditary cancer testing, genomic data management, and reporting services to healthcare providers in Canada.

Ownership category

akta.pro rank

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

TransCan Genomics provides clinical hereditary cancer testing, genomic data management, and reporting services for healthcare providers. The company delivers diagnostic testing along with the data infrastructure and structured clinical reports clinicians need to act on hereditary cancer risk findings.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical hereditary cancer testing Clinical hereditary cancer testing services provided to healthcare providers for patients at risk of hereditary cancer syndromes.
• Genomic data management Genomic data management services for healthcare providers, supporting the handling and organization of genomic information generated from hereditary cancer testing.
• Clinical reporting services Clinical reporting services that deliver structured reports to healthcare providers for use in patient hereditary cancer risk assessment and care.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• GeneDx: GeneDx (now part of Sema4) is a clinical genomics lab with hereditary cancer and rare disease germline panels. Comparable to TransCan Genomics on clinical NGS-based hereditary testing for providers.
• Natera: Natera offers hereditary cancer testing (Empower) alongside reproductive and oncology testing. Directly comparable on hereditary cancer panel offerings and provider-focused commercial motion.
• Ambry Genetics: Ambry Genetics (now part of Labcorp) is a major clinical hereditary cancer and germline testing lab serving providers. Comparable to TransCan Genomics on the core clinical hereditary cancer testing offering and provider-focused go-to-market.
• Invitae: Invitae (now part of Labcorp) offers comprehensive germline genetic testing including hereditary cancer panels. Directly comparable on hereditary cancer panel content, clinician reporting, and health-system partnerships.
• Fulgent Genetics: Fulgent Genetics operates NGS-based clinical testing including hereditary cancer panels and provides data/reporting tools for clinicians. Comparable on testing-plus-software model targeting healthcare providers.
• PreventionGenetics: PreventionGenetics is a clinical lab offering comprehensive hereditary cancer panels with clinician-facing reporting. Directly comparable as a provider-focused germline cancer testing lab.
• Color Genomics: Color provides hereditary cancer screening and clinician reporting infrastructure, including population-health deployments with employers and health systems. Comparable to TransCan Genomics on the testing-plus-data platform model.
• Myriad Genetics: Myriad Genetics is the long-established leader in hereditary cancer testing (BRACAnalysis, myRisk). It directly competes with TransCan Genomics in germline cancer panel testing for healthcare providers, and is the most directly comparable peer given product overlap.

Regional players

• LifeLabs: LifeLabs is Canada's largest community lab and offers a broad menu including hereditary cancer testing. Comparable to TransCan Genomics on Canadian provider-focused clinical lab services, but operates at vastly greater scale and serves general diagnostics rather than specialized genomics.
• Dynacare: Dynacare is a Canadian clinical laboratory offering specialty testing including genetic and hereditary cancer panels. Comparable to TransCan Genomics on Canadian provider-focused clinical lab services in the same geography, though broader in scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TransCan Genomics Inc.